A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

PHASE3CompletedINTERVENTIONAL
Enrollment

459

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

April 30, 2016

Conditions
Newly Diagnosed Multiple Myeloma
Interventions
DRUG

Lenalidomide: Double-blind Induction

Double-blind Induction: the starting lenalidomide oral dosing regimen was 10 mg once daily on Days 1 through 21 of each 28 day cycle for up to 9 cycles. Dose was reduced if needed due to dose-limiting toxicity.

DRUG

Melphalan

Double-blind Induction: the starting melphalan oral dosing regimen in all 3 treatment arms was 0.18 mg/kg daily on Days 1 through 4 of each 28-day cycle for up to 9 cycles. Dose was reduced if needed due to dose-limiting toxicity.

DRUG

Prednisone

Double-blind induction: the starting prednisone oral dosing regimen in all 3 treatment arms was 2 mg/kg daily on Days 1 through 4 of each 28-day cycle for up to 9 cycles. Dose was reduced if needed due to dose-limiting toxicity.

DRUG

Aspirin

"Double-blind induction: low-dose aspirin 75 mg to 100 mg daily for all treatment arms.~Double-blind maintenance: at the investigator's discretion"

DRUG

Placebo

"Double-blind induction: participants in treatment arm MPp+p received placebo once daily on Days 1 through 21 of each 28-day cycle for up to 9 cycles.~Double-blind maintenance: participants in treatment arms MPR+p and MPp+p received placebo once daily on Days 1 through 21 of each 28-day cycle from cycle 10 to disease progression."

DRUG

Lenalidomide: Double-blind Maintenance

Single-agent oral lenalidomide 10 mg once daily on Days 1 through 21 of each 28-day cycle from cycle 10 to disease progression.

DRUG

Lenalidomide: Open-label

Any study participant who had progressive disease had the option of open-label lenalidomide up to 25 mg daily on Days 1 through 21 of each 28-day cycle.

Trial Locations (98)

8

Hope Directorate Haematology Oncology Service St. James Hospital, Dublin

1090

Medical University of Vienna, Vienna

AZ-VUB, Brussels

1160

Wilhelminenspital, Vienna

2050

Royal Prince Alfred Hospital, Camperdown

3000

UZ Gasthuisberg, Leuven

3006

Peter MacCallum Cancer Centre Divsion of Haematology Medical Oncology, East Melbourne

3141

The Alfred Hospital, Melbourne

3199

Frankston Hospital, Frankston

4000

Centre Hospitalier Universitaire de Liege, Liège

4101

Hematology Oncology Clinics of Australia, Level 5, Mater Medical Centre, South Brisbane

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital Institute of Medical and Veterinary Science, Adelaide

5020

University Hospital of Salzburg St Johanns Spital, Salzburg

6009

Sir Charles Gairdner Hospital, Nedlands

6020

University Hospital Innsbruck, Innsbruck

7100

Medicinsk afd. Vejle Sygehus, Vejle

8000

AZ St-Jan Brugge Oostende AV, Bruges

9000

Hæmatologisk afd. B Aalborg Sygehus Syd, Aalborg

10003

Zhitomir Regional Clinical Hospital, Zhytomyr

10117

Medizinische Klinik und Poliklinik II der Charite Campus Mitte, Berlin

10126

Azienda Sanitaria Ospedaliera Molinette S. Giovanni Battista, Turin

11009

Hospital Universitaro Puerta del MarServicio de Hematologia, Cadiz

11525

General Air Force Hospital, Athens

11528

Alexandra General Hospital of Athens, Athens

14033

CHU, Caen

16132

A.O.U. San Martino, Genova

17487

Ernst-Moritz-Arndt-Universität Greifswald, Greifswald

18009

Cherkassy Regional Oncology Center, Cherkassy

20162

Dipartmento Oncologico Struttura Complessa di ematlologiaA.O. Ospedale Niguarda Ca Granda, Milan

20502

Medicinska kliniken, Malmo

27100

Policlinico San Matteo Universita Di Pavia, Pavia

28006

Hospital Universitario de la Princessa, Madrid

31096

Rambam Medical Center, Haifa

34295

CHU Montpellier- Hopital Lapeyronie, Montpellier

34662

Marmara School of Medicine, Istanbul

35100

Ege University Medical School, Izmir

37007

Hospital Universitario de Salamanca, Salamanca

40138

Policlinico S. Orsola, Bologna

41013

Hospital Virgen del Rocio Servicio de Hematologia, Seville

47589

Poliklinik A, Münster

49044

Dnepropetrovsk City Clinical Hospital 4, Dnipro

49100

Hematology Institute, Hemato-Oncology Division,Davidoff Cancer Center, Rabin MC Beilinson Hospital, Petch Tikva

52621

The Chaim Sheba Medical Center, Tel Litwinsky

69120

Universitaetsklinikum Heidelberg Medizinische Klinik und Poliklinik V, Heidelberg

71013

Dipartimento di Onco-Ematologia, San Giovanni Rotondo (FG)

72076

Medizinische Klinik - Abteilung II, Tübingen

75475

Assistance Publique - Hôpitaux de Paris AP-HP, Paris

77520

Fakultni Nemocnice Olomouc, Olomouc

83047

Institute of Urgent and Recovery Surgery, Donetsk

87042

CH - Hôpital Dupuytren, Limoges

89081

Medizinische Universitatsklinik, Ulm

91120

Hadassah University Hospital, Jerusalem

97080

Medizinische Klinik und Poliklinik II des Universitatsklinikums Wurzburg, Würzburg

105229

Burdenko Central Military Clinical Hospital, Moscow

115678

Institution of Russian Academy of Medical Sciences Russian Oncological Research Centre n.a. N. N. Bl, Moscow

129110

Moscow Regional Research Institute n.a. Vladimirsky, Moscow

191024

St. Petersburg Research Institute of Hematology and Blood Transfusion, Saint Petersburg

220116

City Clinical Hospital 9, Minsk

249036

Medical Radiological Research Center RAMS, Obninsk

443095

Samara Regional Clinical Hospital, Samara

630087

Novosibirsk State Regional Clinical Hospital, Novosibirsk

A-1090

Medical University of Vienna, Vienna

246 042

Republican Scientific and Practical Centre of Radiation Medicine and Human Ecology, Homyel

625 00

Fakultni nemocnice Brno, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

128 081

Vseobecna Fakultni Nemocnice v Praze, Prague

TSA 40031-31059

CHU Purpan, Toulouse

0112

Ltd M.Zodelava Hematology Centre, Tbilisi

0177

Institute of Hematology and Transfusiology, Tbilisi

D-01307

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden

D-79106

Universitatsklinikum Freiburg Medizinische Klinik und Poliklinik, Freiburg im Breisgau

D-04103

Medizinische Klinik und Poliklinik II, Leipzig

115 27

G. GENNIMATAS General Hospital of Athens Department of Hematolgosy, Athens

Unknown

Midlands Regional, Tullamore / Co Offally

Universitair Medisch Centrum Utrecht, Utrecht

Institute of Blood Pathology and Transfusion Medicine of the AMS of Ukraine, Lviv

00144

Divisione Di Ematologia Ospedale Cattedra di Ematologia, Rome

00161

Azienda Policlinico Umberto I, Universita La Sapienzadi Roma, Rome

1081 HV

VU Medical Center, Amsterdam

3015 GD/3000 CA

Erasmus Medical Center, Rotterdam

3015 GD

Erasmus Medisch Centrum, Rotterdam

15-276

Klinika Hematologii Samodzielny Publiczny Szpital Kliniczny Akademii, Bialystok

80-211

Institute of Internal Diseases University of Medicine, Gdansk

31-501

Oddzial Kliniczny Kliniki Hematologii, Krakow

93-509

Uniwersytet Medyczny w Lodzi, Lodz

20-290

University School of Medicine, Lublin

02-097

Akademia Medyczna w Warszawie Samodzielny Publiczny Centralny Szpital Kliniczny, Warsaw

08036

Hospital Clinic, Barcelona

501 82

Medicinkliniken, Borås

CH-8091

UniversitatsSpital ZurichKlinik fur Onkologie, Zurich

06620

Ankara University, Ankara

04060

Institute of Hematology and Transfusiology of the UAMS Department of blood diseases, Kiev

ML6 0JS

Monklands Hospital, Aidrie

LS7 9TF

St James's University Hospital, Leeds

NW1 2PG

University College London Hospitals Cancer Clinical Trials Unitist FloorCentral wing, London

SE5 9RS

Kings College Hospital, London

M20 4BX

Christie NHS Trust Hospital, Manchester

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY

NCT00405756 - A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | Biotech Hunter | Biotech Hunter